Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab

Dimitra Stergianou, Vassiliki Tzanetakou, Maria Argyropoulou, Theodora Kanni, Pantelis G Bagos, Evangelos J. Giamarellos-Bourboulis

Dermatology 2021;237(3):372-377
DOI: 10.1159/000512617

View article 🡇

Keywords: Adalimumab; Carriage; Hidradenitis suppurativa; Response; Staphylococcus aureus

2023-02-16T13:26:43+03:00By hiss|Categories: Publications|Tags: Hidradenitis suppurativa|

Related Posts

Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial

Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial

March 14th, 2024 | 0 Comments

qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial

qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial

February 7th, 2024 | 0 Comments

Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein

Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein

February 2nd, 2024 | 0 Comments

Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence

Association of Vitamin D with Severity and Outcome of COVID-19: Clinical and Experimental Evidence

January 5th, 2024 | 0 Comments

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

January 4th, 2024 | 0 Comments

Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa

Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa

October 28th, 2023 | 0 Comments

We use necessary cookies to make our website work properly and to store your choices in relation to optional cookies.
I want to be informed about the Cookies Policy
OK